Rentschler Biopharma Announces Executive Changes and Strategic Phase

Rentschler Biopharma SE, a prominent player in biopharmaceutical contract development and manufacturing, announced executive changes as it enters a new strategic phase. Uwe Buecheler, PhD, Vice Chairman of the Supervisory Board, steps in as interim CEO. This follows a mutual decision for CEO Benedikt von Braunmuehl to step down. The shift aims to bolster long-term growth and value.

Christiane Bardroff, Chief Operating Officer, is also leaving for new opportunities. Her successor is pending announcement. During her tenure, she spearheaded operational advancements, notably increasing production at the Milford and Laupheim sites.

Buecheler emphasizes client satisfaction and business expansion, working closely with the CFO and incoming COO. With over 30 years in the industry, his focus remains on advancing Rentschler Biopharma's mission of quality and reliable partnership.